Names | |
---|---|
IUPAC name
3α,12α-Dihydroxy-5β-cholan-24-oic acid
| |
Systematic IUPAC name
(4R)-4-[(1R,3aS,3bR,5aR,7R,9aS,9bS,11S,11aR)-7,11-Dihydroxy-9a,11a-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-1-yl]pentanoic acid | |
Other names
Deoxycholate
| |
Identifiers | |
3D model (JSmol)
|
|
ChEBI | |
ChEMBL | |
ChemSpider | |
DrugBank | |
ECHA InfoCard | 100.001.344 |
KEGG | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C24H40O4 | |
Molar mass | 392.580 g·mol−1 |
Melting point | 174–176 °C (345–349 °F; 447–449 K) |
0.024%[1] | |
Acidity (pKa) | 6.58[2] |
-272.0·10−6 cm3/mol | |
Pharmacology | |
D11AX24 (WHO) | |
| |
Legal status | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Clinical data | |
---|---|
Trade names | Kybella, Belkyra |
AHFS/Drugs.com | Monograph |
License data | |
Identifiers | |
PDB ligand | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.001.344 |
Deoxycholic acid is a bile acid. Deoxycholic acid is one of the secondary bile acids, which are metabolic byproducts of intestinal bacteria. The two primary bile acids secreted by the liver are cholic acid and chenodeoxycholic acid. Bacteria metabolize chenodeoxycholic acid into the secondary bile acid lithocholic acid, and they metabolize cholic acid into deoxycholic acid. There are additional secondary bile acids, such as ursodeoxycholic acid. Deoxycholic acid is soluble in alcohol and acetic acid. When pure, it exists in a white to off-white crystalline powder form.
Deoxycholic acid is available as a generic medication in the United States as of April 2021, sold under the brand name Kybella among others.[8]